Skip to main content
SpringerLink
Log in

Marshaling the evidence for greater regulation and control of tobacco products: A call for action

  • Health Policy
  • Published:
Annals of Behavioral Medicine

Abstract

Cigarette smoking remains the greatest single cause of preventable death in contemporary society. The health consequences of tobacco use have been documented in thousands of studies. We are at a critical juncture in U.S. tobacco control history. The nation is poised on the brink of momentous changes in the health care system and in public policy regulating the use and marketing of tobacco products. This article will make four recommendations to help us capitalize on these changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pierce JP: Progress and problems in international public health efforts to reduce tobacco usage.Annual Review of Public Health. 1991,12:83–400.

    Article  Google Scholar 

  2. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C: Mortality from tobacco in developed countries: Indirect estimation from national vital statistics.The Lancet. 1992,339 (8804):1268–1278.

    Article  CAS  Google Scholar 

  3. McGinnis JM, Foege WH: Actual causes of death in the United States.Journal of the American Medical Association. 1993,270: 2207–2212.

    Article  PubMed  CAS  Google Scholar 

  4. U.S. Department of Health and Human Services:The Health Consequences of Smoking: Nicotine Addiction. Washington, DC: U.S. Government Printing Office, 1988.

    Google Scholar 

  5. U.S. Department of Health and Human Services:The Health Benefits of Smoking Cessation. Washington, DC: U.S. Government Printing Office, 1990.

    Google Scholar 

  6. U.S. Office on Smoking and Health:Smoking and Health, a National Status Report: A Report to Congress (2nd Ed.). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, 1990.

    Google Scholar 

  7. U.S. Surgeon General:Reducing the Health Consequences of Smoking: Twenty-Five Years of Progress. Rockville, MD: U.S. Department of Health and Human Services, Centers for Disease Control, 1989.

    Google Scholar 

  8. Henningfield JE, Miyasato K, Jasinski DR: Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.Journal of Pharmacology and Experimental Therapeutics. 1985,234:1–12.

    PubMed  CAS  Google Scholar 

  9. American Psychiatric Association:Diagnostic and Statistical Manual-IV Draft Criteria. Task Force on DSM-IV. Washington, DC: American Psychiatric Association, 1993.

    Google Scholar 

  10. Hughes JR: Smoking is a drug dependence: Reply to Robinson and Pritchard.Psychopharmacology, 1993,113:282–283.

    Article  PubMed  CAS  Google Scholar 

  11. Hull CL: The influence of tobacco smoking on mental and motor efficiency.Psychological Monograph. 1924,33.

  12. Russell MAH: Tobacco dependence: Is nicotine rewarding or aversive? In Krasnegor N (ed),Cigarette Smoking as a Dependence Process (NIDA Research Monograph 23). Washington, DC: U.S. Government Printing Office, 1979, 100–122.

    Google Scholar 

  13. Levin ED, Rose JE, Behm F, Caskey N: The effects of smoking-related sensory cues on psychological stress.Pharmacology, Biochemistry and Behavior. 1991,39:265–268.

    Article  CAS  Google Scholar 

  14. Henningfield JE, Goldberg SR: Pharmacologic determinants of tobacco self-administration by humans.Pharmacology, Biochemistry and Behavior. 1988,30:221–226.

    Article  CAS  Google Scholar 

  15. Russell MAH: Nicotine intake and its control over smoking. In Wonnacott S, Russell MAH, Stolennan IP (eds),Nicotine Psychopharmacology: Molecular, Cellular, and Behavioural Aspects. New York: Oxford University Press, 1990, 374–418.

    Google Scholar 

  16. Johnston LM: Tobacco smoking and nicotine.The Lancet. 1942,2:742.

    Google Scholar 

  17. Yokel RA: Intravenous self-administration: Response rates, the effects of pharmacological challenges, and drug preferences. In Bozarth MA (ed),Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag, 1987, 1–34.

    Google Scholar 

  18. Swedberg MDB, Henningfield JE, Goldberg SR: Nicotine dependency: Animal studies. In Wonnacott S, Russell MAH, Stolennan IP (eds),Nicotine Psychopharmacology: Molecular, Cellular, and Behavioural Aspects. New York: Oxford University Press, 1990, 112–157.

    Google Scholar 

  19. Lang WJ, Latiff AA, McQueen A, Singer G: Self-administration of nicotine with and without a food delivery schedule.Pharmacology, Biochemistry and Behavior. 1977,7:65–70.

    Article  CAS  Google Scholar 

  20. Goldberg SR, Spealman RD, Goldberg DM: Persistent high-rate behavior maintained by intravenous self-administration of nicotine.Science. 1981,214:573–575.

    Article  PubMed  CAS  Google Scholar 

  21. Grunberg NE, Acri JB: Conceptual and methodological considerations for tobacco addiction research.British Journal of Addiction. 1991,86(5):637–641.

    Article  PubMed  CAS  Google Scholar 

  22. Balster, RL, Harris LS: Drugs as reinforcers in animals and humans.Federation Proceedings. 1982,41(2):209–210.

    PubMed  CAS  Google Scholar 

  23. Johanson CE, Shuster CR: Animal models of drug self-administration. In Mello NK (ed),Advances in Substance Abuse: Behavioral and Biological Research (Vol. 2). Greenwich, CT: JAI Press, 1981, 219–297.

    Google Scholar 

  24. Young AM, Herling S: Drugs as reinforcers: Studies in laboratory animals. In Goldberg SR, Stolerman IP (eds),Behavioral Analysis of Drug Dependence. London: Academic Press, Inc., 1986, 9–67.

    Google Scholar 

  25. Corrigall WA, Coen KM: Nicotine maintains robust self-administration in rats on a limited-access schedule.Psychopharmacology. 1989,99:473–478.

    Article  PubMed  CAS  Google Scholar 

  26. Goldberg SR, Spealman RD, Risner ME, Henningfield JE: Control of behavior by intravenous nicotine injections in laboratory animals.Pharmacology, Biochemistry and Behavior. 1983,19:1011–1020.

    Article  CAS  Google Scholar 

  27. Nowak R: Key study unveiled — 11 years late.Science. 1994,264: 196–197.

    PubMed  CAS  Google Scholar 

  28. Henningfield JE, Goldberg SR: Control of behavior by intravenous nicotine injections in human subjects.Pharmacology, Biochemistry and Behavior. 1983,19:1021–1026.

    Article  CAS  Google Scholar 

  29. Hughes JR, Pickens RW, Spring W, Keenan RM: Instructions control whether nicotine will serve as a reinforcer.Journal of Pharmacology and Experimental Therapeutics. 1985,255:106–112.

    Google Scholar 

  30. Kozlowski LT, Wilkinson A, Skinner W, et al: Comparing tobacco cigarette dependence with other drug dependencies.Journal of the American Medical Association. 1989,267:898–901.

    Article  Google Scholar 

  31. Kolonen S, Toumisto J, Puustinen P, Airaksinen MM: Effects of smoking abstinence and chain-smoking on puffing topography and diurnal nicotine exposure.Pharmacology, Biochemistry and Behavior. 1992,42:327–332.

    Article  CAS  Google Scholar 

  32. Rose JE, Sampson A, Levin ED, Henningfield JE: Mecamylamine increases nicotine preference and attenuates nicotine discrimination.Pharmacology, Biochemistry and Behavior. 1989,32:933–938.

    Article  CAS  Google Scholar 

  33. Yanagita T, Ando K, Kato S, Takada K: Psychopharmacological studies on nicotine and tobacco smoking in rhesus monkeys.Psychopharmacology Bulletin. 1983,79:409–412.

    Google Scholar 

  34. Perkins KA: Maintaining smoking abstinence after myocardial infarction.Journal of Substance Abuse. 1988,7:91–107.

    Article  Google Scholar 

  35. Shiftman S: Smoking cessation treatment: Any progress?Journal of Consulting and Clinical Psychology. 1993,67:718–722.

    Article  Google Scholar 

  36. Benowitz NL: Nicotine replacement therapy.Drugs. 1993,45: 157–170.

    Article  PubMed  CAS  Google Scholar 

  37. Henningfield JE, Keenan R: Nicotine delivery kinetics and abuse liability.Journal of Consulting and Clinical Psychology. 1993,67:743–750.

    Article  Google Scholar 

  38. Henningfield JE, Woodson PP: Dose-related actions of nicotine on behavior and physiology: Review and implications for replacement therapy for nicotine dependence.Journal of Substance Abuse. 1989,7:301–317.

    Google Scholar 

  39. Clarke PBS: Dopaminergic mechanisms in the locomotor stimulant effects of nicotine.Biochemical Pharmacology. 1990,40: 1427–1432.

    Article  PubMed  CAS  Google Scholar 

  40. Perkins KA, Grobe JE, Fonte C, et al: Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans.Journal of Pharmacology and Experimental Therapeutics (in. press, 1995).

  41. McNeill AD: The development of dependence on smoking in children.British Journal of Addiction. 1991,86:589–592.

    Article  PubMed  CAS  Google Scholar 

  42. Perkins KA, Grobe JE, Stiller RL, et al: Effects of nicotine on thermal pain detection in humans.Experimental and Clinical Psychopharmacology. 1994,2:95–106.

    Article  Google Scholar 

  43. Hughes JR, Higgins ST, Hatsukami DK: Effects of abstinence from tobacco: A critical review. In Kozlowski LT, Annis H, Cap-pell HD, et al (eds),Research Advances in Alcohol and Drug Problems (Vol. 10). New York: Plenum Press, 1990, 317–398.

    Google Scholar 

  44. Malin DH, Lake JR, Newlin-Maultsby P, et al: Rodent model of nicotine abstinence syndrome.Pharmacology, Biochemistry and Behavior. 1992,43:779–784.

    Article  CAS  Google Scholar 

  45. National Research Council:Environmental Tobacco Smoke: Measuring Exposures and Health Effects. Washington, DC: National Academy Press, 1986.

    Google Scholar 

  46. World Health Organization:Tobacco Price and the Smoking Epidemic: Smoke-Free Europe-9. Copenhagen, Denmark: World Health Organization, 1987.

    Google Scholar 

  47. Lewit EM, Coate D: The potential of using excise taxes to reduce smoking.Journal of Health Economics. 1982,7:121–145.

    Article  Google Scholar 

  48. Hu T, Bai J, Keeler TE, Barnett PG: The impact of a large tax increase on cigarette consumption: The case of California. Unpublished Manuscript, University of California, Berkeley, 1991.

    Google Scholar 

  49. Chaloupka F: Testimony to the U.S. House of Representatives, Committee on Ways and Means, November 18, 1994.

  50. Behney C, Hewitt M: Testimony to the U.S. House of Representatives, Committee on Ways and Means, November 18, 1994.

  51. Harris JE: Testimony to the U.S. House of Representatives, Committee on Ways and Means, November 18, 1994.

  52. Kaplan RM:The Hippocratic Predicament: Affordability, Access, and Accountability in American Medicine. San Diego, CA: Academic Press, 1993.

    Google Scholar 

  53. Pierce JP, Farkas A, Evans N, et al:Tobacco Use in California, 1992. Sacramento, CA: California Department of Public Health, 1992.

    Google Scholar 

  54. Warner KE: Smoking and health implications of a change in federal cigarette excise tax.Journal of the American Medical Association. 1986,255:1028–1032.

    Article  PubMed  CAS  Google Scholar 

  55. Gilpin EA, Lee L, Evans N, Pierce JP: Smoking initiation rates in adults and minors: United States, 1944–1988.American Journal of Epidemiology (in press, 1995).

  56. Centers for Disease Control: Cigarette advertising—United States, 1988.Morbidity and Mortality Weekly Report. 1990,39:261–265.

    Google Scholar 

  57. Klonoff EA, Fritz JM, Landrine H, Riddle RW, Tully-Payne L: The problem and sociocultural context of single-cigarette sales.Journal of the American Medical Association. 1994,277:618–620.

    Article  Google Scholar 

  58. DiFranza JR, Brown LJ: The Tobacco Institute’s “It’s the Law” campaign: Has it halted illegal sales of tobacco to children?American Journal of Public Health. 1992,82:1271–1273.

    PubMed  CAS  Google Scholar 

  59. DiFranza JR, Richards JW, Paulman PM, et al: RJR Nabisco’s cartoon camel promotes Camel cigarettes to children.Journal of the American Medical Association. 1991,266:3149–3153.

    Article  PubMed  CAS  Google Scholar 

  60. Fischer PM, Schwartz MP, Richards JJW, Goldstein AO, Rojas TH: Brand logo recognition by children aged 3 to 6 years. Mickey Mouse and Old Joe the Camel.Journal of the American Medical Association. 1991,266:3145–3148.

    Article  PubMed  CAS  Google Scholar 

  61. Gostin LO, Brandt AM: Criteria for evaluating a ban on the advertisement of cigarettes. Balancing public health benefits with constitutional burdens.Journal of the American Medical Association. 1993,269:904–909.

    Article  PubMed  CAS  Google Scholar 

  62. Ill ML, Kroll LA: Tobacco advertising and the First Amendment.Journal of the American Medical Association. 1990,264:1593–1594.

    Article  Google Scholar 

  63. U.S. Department of Health and Human Services:Tobacco Use in 1986. Methods and Basic Tabulations from Adult Use of Tobacco Survey. Rockville, MD: Public Health Service, 1986.

    Google Scholar 

  64. Catanoso J: “Old Joe’s Influence Inflated, Study Says.”Greensboro News and Record, 14 April 1993, A6.

    Google Scholar 

  65. Leventhal H, Cleary PD: The smoking problem: A review of research and theory in behavior risk modification.Psychological Bulletin. 1980,88:370–105.

    Article  PubMed  CAS  Google Scholar 

  66. Pierce JP, Gilpin E, Burns DM, et al: Does tobacco advertising target young people to start smoking? Evidence from California.Journal of the American Medical Association. 1991,266:3154–3158.

    Article  PubMed  CAS  Google Scholar 

  67. Rice DP, Max W:The Cost of Smoking in California. Sacramento, CA: Department of Health Services, 1992.

    Google Scholar 

  68. Albright CL, Altman DF, Slater MD, Maccoby N: Cigarette advertisements in magazines: Evidence for a differential focus on women’s and youth magazines.Health Education Quarterly. 1988,75:225–233.

    Google Scholar 

  69. Ernster VL: Mixed messages for women: A social history of cigarette smoking and advertising.New York State Journal of Medicine. 1985,55:335–340.

    Google Scholar 

  70. Pierce JP, Lee L, Gilpin EA: Smoking initiation by adolescent girls, 1944 through 1988. An association with targeted advertising.Journal of the American Medical Association. 1994,271:608–611.

    Article  PubMed  CAS  Google Scholar 

  71. Orleans CT, Slade J (eds):Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993.

    Google Scholar 

  72. U.S. Department of Health and Human Services:Surgeon General’s Report: Preventing Tobacco Use among Young People. Washington, DC: U.S. Government Printing Office, 1994.

    Google Scholar 

  73. Schauffler HH, Parkinson MD: Health insurance coverage for smoking cessation.Health Education Quarterly. 1993,20:185–206.

    PubMed  CAS  Google Scholar 

  74. Fiore M, Novotny T, Pierce J, et al: Methods used to quit smoking in the United States: Do cessation programs help?Journal of the American Medical Association. 1990,268:2687–2694.

    Article  Google Scholar 

  75. Glynn TJ, Manley MW, Solberg LI, Slade J: Creating and maintaining an optimal medical practice environment for the treatment of nicotine addiction. In Orleans CT, Slade J (eds),Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993, 162–181.

    Google Scholar 

  76. McCinnis JM: Trends and issues in financing: Payment for smoking cessation services.Tobacco Control. 1993,2(Suppl.):S38-S40.

    Article  Google Scholar 

  77. Lando H: Formal quit smoking treatments. In Orleans CT, Slade J (eds),Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993, 221–245.

    Google Scholar 

  78. Lichtenstein E, Glasgow RE: Smoking cessation: What have we learned over the past decade?Journal of Consulting and Clinical Psychology. 1992,60:518–527.

    Article  PubMed  CAS  Google Scholar 

  79. U.S. Department of Health and Human Services:Surgeon General’s Report: The Health Consequences of Smoking: Nicotine Addiction. Washington, DC: U.S. Government Printing Office, 1988.

    Google Scholar 

  80. Abrams D: Treatment issues: Towards a stepped-care model.Tobacco Control. 1993,2(Suppl.):S17-S30.

    Google Scholar 

  81. Orleans CT, Glynn TM, Manley M, Slade J: Minimal-contact quit smoking strategies for medical settings. In Orleans CT, Slade J (eds),Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993, 181–221.

    Google Scholar 

  82. Glynn TJ, Boyd G, Gruman JC:Self-Guided Strategies for Smoking Cessation: A Program Planner’s Guide, NIH Publication No. 91-33104. Washington, DC: U.S. Government Printing Office, 1991.

    Google Scholar 

  83. Cohen S, Lichtenstein E, Prochaska JO, et al: Debunking myths about self-quitting.American Psychologist. 1989,44:1355–1365.

    Article  PubMed  CAS  Google Scholar 

  84. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS: Standardized, individualized, interactive, and personalized self-help programs for smoking cessation.Health Psychology. 1993,12(5): 399–405.

    Article  PubMed  CAS  Google Scholar 

  85. Hurt RD, Dale LC, McClain FL, et al: A comprehensive model for the treatment of nicotine dependence in a medical setting.Mayo Clinic Proceedings. 1990,65:1529–1537.

    PubMed  CAS  Google Scholar 

  86. Fiore M, Jorenby DE, Baker TB, Kenford SL: Tobacco dependence and the nicotine patch: Clinical guidelines for effective use.Journal of the American Medical Association. 1992,265:2687–2694.

    Article  Google Scholar 

  87. Hughes JR: Pharmacotherapy for smoking cessation: Unvali-dated assumptions, anomalies, and suggestions for future research.Journal of Consulting and Clinical Psychology. 1993,61(5): 751–760.

    Article  PubMed  CAS  Google Scholar 

  88. Fiore M: The new vital sign: Assessing and documenting smoking status.Journal of the American Medical Association. 1991,22: 3183–3184.

    Article  Google Scholar 

  89. Lerman CL, Orleans CT, Engstrom PF: Biological markers in smoking cessation treatment.Seminars in Oncology. 1993,20: 359–367.

    PubMed  CAS  Google Scholar 

  90. Risser NL, Belcher D: Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: A randomized trial.Journal of General Internal Medicine. 1990,5: 16–22.

    Article  PubMed  CAS  Google Scholar 

  91. Emmons KM, Goldstein MG: Smokers who are hospitalized: A window of opportunity for cessation interventions.Preventive Medicine. 1992,27:262–269.

    Article  Google Scholar 

  92. Gritz ER, Kristeller J, Burns D: Treating nicotine addiction in high-risk groups and patients with medical co-morbidity. In Orleans CT, Slade J (eds),Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993, 279–309.

    Google Scholar 

  93. Orleans CT, Kristeller J, Gritz ER: Helping hospitalized smokers quit: New directions for treatment and research.Journal of Consulting and Clinical Psychology. 1993,67:778–789.

    Article  Google Scholar 

  94. Glynn TJ, Manley MW: Physicians, cancer control, and the treatment of nicotine dependence: Denning success.Health Education Research. 1989,4:479–487.

    Article  Google Scholar 

  95. Kottke TE, Battista RN, DeFriese G, et al: Attributes of successful smoking cessation interventions in medical practice: A metaanalysis of 39 trials.Journal of the American Medical Association. 1988,259:2883–2889.

    Article  PubMed  CAS  Google Scholar 

  96. Ockene JK: Physician-delivered interventions for smoking cessation: Strategies for increasing effectiveness.Preventive Medicine. 1987,76:723–737.

    Article  Google Scholar 

  97. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF: Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention.Annals of Internal Medicine. 1990,775: 118–123.

    Google Scholar 

  98. Orleans CT, Rimer BK, Cristinzio S, Keintz MK, Fleisher L: A national survey of older smokers: Treatment needs of a growing population.Health Psychology. 1991,10(5):343–351.

    Article  PubMed  CAS  Google Scholar 

  99. Hurt RD, Eberman KM, Slade J, Karan L: Treating nicotine addiction in patients with other addictive disorders. In Orleans CT, Slade J (eds),Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993, 310–326.

    Google Scholar 

  100. Eddy D: David Eddy ranks the tests.Harvard Health Letter. 1992,July(Suppl.): 10–11.

    Google Scholar 

  101. Warner K: Policy issues.Tobacco Control. 1993,2(Suppl.):S79-S84.

    Google Scholar 

  102. Cummings SR, Rubin SM, Oster G: The cost-effectiveness of counseling smokers to quit.Journal of the American Medical Association. 1991,265:2218–2225.

    Article  Google Scholar 

  103. Oster J, Huse DM, Delea TE, et al: Cost-effectiveness of nicotine gum as an adjunct to physician’s advice against cigarette smoking.Journal of the American Medical Association. 1986,256:1315–1318.

    Article  PubMed  CAS  Google Scholar 

  104. Britt J, Curry SJ, McBride C, Grothaus L, Louie D: Implementation and acceptance of outreach telephone counseling for smoking cessation with non-volunteer smokers.Health Education Quarterly. 1994,21(1):55–68.

    PubMed  CAS  Google Scholar 

  105. Marks JS, Koplan JP, Hogue C, Dalmat ME: A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women.American Journal of Preventive Medicine. 1992,6:282–289.

    Google Scholar 

  106. Windsor RA, Lowe JB, Perkins LL, et al: Health education for pregnant smokers: Its behavioral impact and cost benefit.American Journal of Public Health. 1993,83(2):201–206.

    PubMed  CAS  Google Scholar 

  107. Krumholz HM, Cohen BJ, Tsevat J, et al: Cost-effectiveness of a smoking cessation program after myocardial infarction.Journal of the American College of Cardiology. 1993,22:1697–1702.

    Article  PubMed  CAS  Google Scholar 

  108. Coalition on Smoking or Health: Tobacco excise taxes: A reliable source of revenue. Washington, DC: Coalition on Smoking or Health, 1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, University of California, San Diego, La Jolla, USA

    Robert M. Kaplan & C. Tracy Orleans

  2. University of Pittsburgh, Pittsburgh, USA

    Kenneth A. Perkins & John P. Pierce

  3. University of California, San Diego, La Jolla, USA

    Kenneth A. Perkins & John P. Pierce

Authors
  1. Robert M. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Tracy Orleans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth A. Perkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John P. Pierce
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The order of authorship is alphabetical.

The authors are grateful to Dennis C. Turk, Ellen Gritz, and Neil E. Grunberg for providing constructive feedback on an earlier version of this paper.

About this article

Cite this article

Kaplan, R.M., Orleans, C.T., Perkins, K.A. et al. Marshaling the evidence for greater regulation and control of tobacco products: A call for action. Ann Behav Med 17, 3–14 (1995). https://doi.org/10.1007/BF02888801

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02888801

Keywords

Search

Navigation